Drug Discovery Today: Technologies
Published by Elsevier
ISSN : 1740-6749
Abbreviation : Drug Discov. Today Technol.
Aims & Scope
The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process.
It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs.
This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.
View Aims & ScopeMetrics & Ranking
Journal Rank
Year | Value |
---|---|
2024 | 3437 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 107 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.223 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 68 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Citation: 631
Authors: Mariell, Craig M.
-
A compact review of molecular property prediction with graph neural networks
Citation: 370
Authors: Oliver, Stefan, Mélaine, Arthur, Pierre, Thomas, Thierry
-
The production of 3D tumor spheroids for cancer drug discovery
Citation: 340
Authors: Shilpa, Paul A.
-
Subcutaneous drug delivery and the role of the lymphatics
Citation: 222
Authors: Danielle N., Christopher J.H., Susan A.
-
Clinical trials for BET inhibitors run ahead of the science
Citation: 219
Authors: Guillaume, Anna C., Gerald V.
-
‘In silico’ simulations to assess the ‘in vivo’ consequences of ‘in vitro’ metabolic drug–drug interactions
Citation: 206
Authors: Amin, Geoff